Company Filing History:
Years Active: 2021-2025
Title: Paymaan Jafar-nejad: Innovator in Pharmaceutical Sciences
Introduction
Paymaan Jafar-nejad is a prominent inventor based in Carlsbad, CA (US). He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds and methods for treating various neurogenetic disorders. With a total of 4 patents to his name, Jafar-nejad is recognized for his innovative approaches to complex medical challenges.
Latest Patents
One of his latest patents focuses on "Compounds and methods for modulating SCN2A." This invention provides compounds, methods, and pharmaceutical compositions aimed at reducing the amount or activity of SCN2A RNA in a cell or subject. The implications of this work are profound, as it addresses symptoms associated with disorders such as Developmental and Epileptic Encephalopathy, intellectual disabilities, and autism spectrum disorders. The patent outlines how these compounds can ameliorate symptoms including seizures, motor development delays, and cognitive dysfunctions.
Another significant patent by Jafar-nejad is titled "Compounds and methods for modulating UBE3A-ATS." This invention involves compounds and methods designed to reduce the activity of UBE3A-ATS, the endogenous antisense transcript of ubiquitin protein ligase E3A. This work is particularly relevant for treating neurogenetic disorders like Angelman Syndrome, as it aims to increase the expression of paternal UBE3A and improve various symptoms such as developmental delays and seizures.
Career Highlights
Paymaan Jafar-nejad is currently employed at Ionis Pharmaceuticals, Inc., where he continues to push the boundaries of pharmaceutical innovation. His work is characterized by a commitment to addressing critical health issues through scientific research and development.
Collaborations
Throughout his career, Jafar-nejad has collaborated with esteemed colleagues, including Susan M. Freier and Huynh-Hoa Bui. These partnerships have further enhanced his research capabilities and contributed to the advancement of his projects.
Conclusion
Paymaan Jafar-nejad stands out as a key figure in the realm of pharmaceutical innovation. His patents and ongoing research efforts reflect a dedication to improving the lives of individuals affected by neurogenetic disorders. His contributions are paving the way for future advancements in medical science.